Compare ESQ & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESQ | STAA |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | United States |
| Employees | 151 | N/A |
| Industry | Commercial Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 910.9M | 867.9M |
| IPO Year | 2017 | 1995 |
| Metric | ESQ | STAA |
|---|---|---|
| Price | $108.10 | $18.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 9 |
| Target Price | ★ $120.33 | $22.19 |
| AVG Volume (30 Days) | 71.3K | ★ 1.3M |
| Earning Date | 04-23-2026 | 03-03-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | ★ 14.20 | N/A |
| EPS | ★ 5.87 | N/A |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $28.65 | $33.83 |
| Revenue Next Year | $4.95 | $8.16 |
| P/E Ratio | $17.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $69.14 | $14.69 |
| 52 Week High | $119.86 | $30.81 |
| Indicator | ESQ | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 54.42 | 50.63 |
| Support Level | $91.62 | $17.13 |
| Resistance Level | $112.17 | $19.79 |
| Average True Range (ATR) | 3.81 | 1.01 |
| MACD | 0.65 | 0.02 |
| Stochastic Oscillator | 65.00 | 65.33 |
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.